Search   
MSDS  : 5-beta-Cholan-24-oic acid, 3-alpha,7-beta-dihydroxy-
CAS  : 128-13-2
SYNONYMS  : * Acido ursodeossicolico * Actigall * Arsacol * Cholan-24-oic acid, 3,7-dihydroxy-, (3-alpha,5-beta,7-beta)- * Cholit-ursan * Delursan * Destolit * Deursil * 3-alpha,7-beta-Dihydroxycholanic acid * 3,7-Dihydroxycholan-24-oic acid * 3-alpha,7-beta-Dihydroxy-5-beta-cholanoic acid * 3-alpha,7-beta-Dioxycholanic acid * 7-beta-Hydroxylithocholic acid * Litursol * Lyeton * 17-beta-(1-Methyl-3-carboxypropyl)etiocholane-3-alpha,7-beta-diol * Peptarom * Solutrat * UDCA * Ursacol * UrSO * Ursobilin * Ursochol * Ursodamor * Ursodeoxycholic acid * Ursodesoxycholic acid * Ursodiol * Ursofalk * Ursolvan
*** CHEMICAL IDENTIFICATION ***

RTECS NUMBER : FZ2000000
CHEMICAL NAME : 5-beta-Cholan-24-oic acid, 3-alpha,7-beta-dihydroxy-
CAS REGISTRY NUMBER : 128-13-2
OTHER CAS REGISTRY NOS. : 50809-41-1
BEILSTEIN REFERENCE NO. : 3219888
REFERENCE : 4-10-00-01604 (Beilstein Handbook Reference)
LAST UPDATED : 199706
DATA ITEMS CITED : 22
MOLECULAR FORMULA : C24-H40-O4
MOLECULAR WEIGHT : 392.64
WISWESSER LINE NOTATION : L E5 B666TJ A1 E1 FY1&2VQ KQ OQ
COMPOUND DESCRIPTOR : Drug
Mutagen
Reproductive Effector
SYNONYMS/TRADE NAMES :
* Acido ursodeossicolico
* Actigall
* Arsacol
* Cholan-24-oic acid, 3,7-dihydroxy-, (3-alpha,5-beta,7-beta)-
* Cholit-ursan
* Delursan
* Destolit
* Deursil
* 3-alpha,7-beta-Dihydroxycholanic acid
* 3,7-Dihydroxycholan-24-oic acid
* 3-alpha,7-beta-Dihydroxy-5-beta-cholanoic acid
* 3-alpha,7-beta-Dioxycholanic acid
* 7-beta-Hydroxylithocholic acid
* Litursol
* Lyeton
* 17-beta-(1-Methyl-3-carboxypropyl)etiocholane-3-alpha,7-beta-diol
* Peptarom
* Solutrat
* UDCA
* Ursacol
* UrSO
* Ursobilin
* Ursochol
* Ursodamor
* Ursodeoxycholic acid
* Ursodesoxycholic acid
* Ursodiol
* Ursofalk
* Ursolvan

*** HEALTH HAZARD DATA ***

** ACUTE TOXICITY DATA **

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 4600 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
BCFAAI Bollettino Chimico Farmaceutico. (Societa Editoriale Farmaceutica,
Via Ausonio 12, 20123 Milan, Italy) V.33- 1894- Volume(issue)/page/year:
126,282,1987

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 700 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
BCFAAI Bollettino Chimico Farmaceutico. (Societa Editoriale Farmaceutica,
Via Ausonio 12, 20123 Milan, Italy) V.33- 1894- Volume(issue)/page/year:
126,282,1987

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : >2 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 9,3159,1975

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 310 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
Behavioral - convulsions or effect on seizure threshold
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 9,3159,1975

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : >10 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 9,3159,1975

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 1200 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
Skin and Appendages - hair
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 9,3159,1975

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 1 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
85IQAH "Modern Pharmaceuticals of Japan, IV," Tokyo, Japan Pharmaceutical,
Medical and Dental Supply Exporters' Assoc., 1972 Volume(issue)/page/year:
-,109,1972

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 240 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
Behavioral - convulsions or effect on seizure threshold
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 9,3159,1975

** OTHER MULTIPLE DOSE TOXICITY DATA **

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 91 gm/kg/13W-I
TOXIC EFFECTS :
Gastrointestinal - hypermotility, diarrhea
Liver - hepatitis (hepatocellular necrosis), zonal
Blood - changes in serum composition (e.g. TP, bilirubin, cholesterol)
REFERENCE :
YACHDS Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu
Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972-
Volume(issue)/page/year: 10,4507,1982

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 91 gm/kg/26W-I
TOXIC EFFECTS :
Liver - hepatitis (hepatocellular necrosis), diffuse
Liver - other changes
Blood - changes in serum composition (e.g. TP, bilirubin, cholesterol)
REFERENCE :
YACHDS Yakuri to Chiryo. Pharmacology and Therapeutics. (Raifu Saiensu
Shuppan K.K., 2-5-13, Yaesu, Chuo-ku, Tokyo 104, Japan) V.1- 1972-
Volume(issue)/page/year: 10,4529,1982

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 3750 mg/kg/5W-I
TOXIC EFFECTS :
Liver - changes in liver weight
Kidney, Ureter, Bladder - changes in bladder weight
Nutritional and Gross Metabolic - weight loss or decreased weight gain
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 9,3183,1975

** REPRODUCTIVE DATA **

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE : 11900 mg/kg
SEX/DURATION : female 4-20 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - litter size (e.g. # fetuses per litter; measured
before birth)
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death,
e.g., stunted fetus)
REFERENCE :
AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. (Heymans
Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4-
1898- Volume(issue)/page/year: 246,149,1980

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE : 24 gm/kg
SEX/DURATION : female 9-14 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death,
e.g., stunted fetus)
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 9,3223,1975

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE : 11 gm/kg
SEX/DURATION : female 7-17 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Newborn - stillbirth
Reproductive - Effects on Newborn - live birth index (measured after birth)
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180,
Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 15,931,1978

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE : 22 gm/kg
SEX/DURATION : male 9 week(s) pre-mating
female 2 week(s) pre-mating
female 1-7 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - musculoskeletal system
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180,
Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 15,923,1978

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - rat
DOSE : 1200 mg/kg
SEX/DURATION : female 9-14 day(s) after conception
TOXIC EFFECTS :
Reproductive - Maternal Effects - other effects
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death,
e.g., stunted fetus)
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 9,3223,1975

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE : 9 gm/kg
SEX/DURATION : female 7-12 day(s) after conception
TOXIC EFFECTS :
Reproductive - Maternal Effects - other effects
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death,
e.g., stunted fetus)
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 9,3223,1975

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - mouse
DOSE : 1200 mg/kg
SEX/DURATION : female 7-12 day(s) after conception
TOXIC EFFECTS :
Reproductive - Maternal Effects - other effects
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 9,3223,1975

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rabbit
DOSE : 130 mg/kg
SEX/DURATION : female 6-18 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Newborn - sex ratio
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180,
Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 15,1133,1978

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rabbit
DOSE : 65 mg/kg
SEX/DURATION : female 6-18 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Newborn - physical
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180,
Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 15,1133,1978

** MUTATION DATA **

TYPE OF TEST : Mutation in microorganisms
TEST SYSTEM : Bacteria - Salmonella typhimurium
DOSE/DURATION : 40 mg/L
REFERENCE :
MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE
Amsterdam, Netherlands) V.1- 1964- Volume(issue)/page/year: 158,45,1985

TYPE OF TEST : Mutation in microorganisms
TEST SYSTEM : Yeast - Saccharomyces cerevisiae
DOSE/DURATION : 51 mmol/L
REFERENCE :
ARTODN Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000
Berlin 33, Fed. Rep. Ger.) V.32- 1974- Volume(issue)/page/year:
60,192,1987

*** END OF RECORD ***
Search More   
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
NAMECAS
Chloric acid, sodium salt, mixt. with urea 102340-92-1
Chloric acid, thallium(1+) salt 13453-30-0
Chloriertes camphenSUBSTANCE DEFINITION :Consists of a mixture of chlorinated camphene with 67-69% chlorineREFERENCE :85GYAV "Pflanzenschutz-und Schaedlingsbekaempfungsmittel: Abriss einerToxikologie und Therapie von Vergiftungen," 2nd ed., Klimmer, O.R.,Hattingen, Fed. Rep. Ger., Hundt-Verlag, 1971 Volume(issue)/page/year:-,50,1971 13453-30-0
Chlorinated poly(vinyl chloride), pyrolyzate 13453-30-0
5-beta-Card-20(22)-enolide,3-beta-((2,6-dideoxy-3,4-O-(1-phenylmethyl)propylidene)-beta-D- ribo-hexopyranosyl)-5,14-dihydroxy-19-oxo- 35811-18-8
Chlorinated trisodium phosphate 11084-85-8
Chlorine 7782-50-5
Chlorine fluoride 7790-91-2
Chlorine fluoride (ClF5) 13637-63-3
Chlorine oxide 10049-04-4
Chlorisofos 76774-73-7
Chlorite 14998-27-7
Chlorocarcin A, dihydrochloride, hydrate 14998-27-7
Chlorocarcin B 59493-95-7
Chloroform 67-66-3
Card-20(22)-enolide,3-((2,6-dideoxy-4-O-beta-D-xylopyranosyl-beta-D-ribo-hexopyranosyl)oxy)- 5,14-dihydroxy-19-oxo-,(3-beta,5-beta)- 630-65-9
Chloroparaffin XP-470 630-65-9
Chlorophyll 1406-65-1
Chloroprene rubber 1406-65-1
Chlorostatin 37246-59-6
Chlorosulfuric acid 7790-94-5
Chlorosulfuric acid, (2-chloroethyl) ester 13891-58-2
Chlorosulfuric acid, (2-fluoroethyl) ester 371-94-8
Chlorothricin, 2(A)-hydroxy-, (2(A)R)-, (9CI) 111810-18-5
Chlorous acid, silver(1+) salt 7783-91-7
Chocolate Brown FB 12236-46-3
Card-20(22)-enolide,3-((diethylaminoacetyl)oxy)-5,14-dihydroxy-19-oxo-,(3-beta,5-beta)- 63979-66-8
Choerospondias axillaris (roxb.) Burtt. et Hill,fruit extract 63979-66-8
Choji (Japanese)SUBSTANCE DEFINITION :Crude drug extract from Syzygium aromaticaREFERENCE :MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AEAmsterdam, Netherlands) V.1- 1964- 63979-66-8
Cholan-24-oic acid, 3,7-bis(sulfooxy)-, trisodiumsalt, (3-alpha,5-beta,7-beta)- 89232-83-7
5-beta-Cholan-24-oic acid, 3-alpha,7-alpha-dihydroxy- 474-25-9
5-beta-Cholan-24-oic acid, 3-alpha,7-beta-dihydroxy- 128-13-2
5-beta-Cholan-24-oic acid, 3-alpha,6-alpha-dihydroxy- 83-49-8
5-beta-Cholan-24-oic acid,3-alpha,12-alpha-dihydroxy- 83-44-3
5-beta-Cholan-24-oic acid,3-alpha,12-alpha-dihydroxy- compd. with acenaphthene 83-44-3
5-beta-Cholan-24-oic acid,3-alpha,12-alpha-dihydroxy-, compd. withcholanthrene, 3-methyl- 83-44-3
5-beta-Cholan-24-oic acid,3-alpha-12-alpha-dihydroxy-, compound withdibenz(a,h)anthracene 83-44-3
5-alpha-Card-20(22)-enolide, 3-alpha,14-dihydroxy- 466-08-0
5-beta-Cholan-24-oic acid,3-alpha,7-alpha-dihydroxy-, monosodium salt 2646-38-0
Cholan-24-oic acid, 3,7-dihydroxy-12-oxo-, sodiumsalt 2646-38-0
Cholan-24-oic acid, 3,12-dihydroxy-7-oxo-, sodiumsalt 2646-38-0
Cholan-24-oic acid, 7,12-dihydroxy-3-oxo-, sodiumsalt 2646-38-0
5-beta-Cholan-24-oic acid,3-alpha,6-alpha-dihydroxy-, sodium salt 31687-62-4
5-beta-Cholan-24-oic acid,3-alpha,12-alpha-dihydroxy-, sodium salt 302-95-4
5-beta-Cholan-24-oic acid, 3,12-dioxo- 2958-05-6
Cholan-24-oic acid, 3,7-dioxo-12-hydroxy-, sodiumsalt 2958-05-6
Cholan-24-oic acid, 3,12-dioxo-7-hydroxy-, sodiumsalt 2958-05-6
Cholan-24-oic acid, 7,12-dioxo-3-hydroxy-, sodiumsalt 2958-05-6
5-beta-Card-20(22)-enolide, 3-alpha,14-dihydroxy- 545-52-8
5-beta-Cholan-24-oic acid, 3,6-dioxo-, sodium salt 545-52-8

Free MSDS Search ( Providing 250,000+ Material Properties )
Chemcas.com| Ads link:todaystock.net